Session Details
[1S13a]Smart Control of Tau: From Pathobiology and Biomarkers to Next-Generation Therapeutics for Dementia
Thu. Jul 30, 2026 2:50 PM - 4:50 PM JST
Thu. Jul 30, 2026 5:50 AM - 7:50 AM UTC
Thu. Jul 30, 2026 5:50 AM - 7:50 AM UTC
Room 13 (2F Exhibiton Hall B)
Organizer: Shinsuke Ishigaki (Shiga University of Medical Science, Molecular Neuroscience Research Center), Seiko Ikezu (Mayo Clinic College of Medicine and Science)
[1S13a-01]Dissecting early pathogenic events in tauopathy: from synaptic dysfunction to optogenetic control of tau aggregation
*Hiroko Bannai1 (1. Waseda University)
[1S13a-02]Tau Deficiency Disrupts the Reward System: Implications for Tau-Targeted Therapies
*Yusuke Fujioka1 (1. Shiga University of Medical Science)
[1S13a-03]Blood-based tau biomarkers in Alzheimer’s disease and other tauopathies
*Takahiko Tokuda1 (1. Osaka Metropolitan University Graduate School of Medicine)
[1S13a-04]Tau interactome in brain-derived extracellular vesicles uncovers a novel driver of tau pathology in Alzheimer’s disease
*Tsuneya Ikezu1, Zhengrong Zhang1, Yang You1, Kaiwen Yu2, Michael A DeTure1, Zbigniew K. Wszolek1, Dennis W. Dickson1, Junmin Peng2, Seiko Ikezu1 (1. Mayo Clinic Florida, Jacksonville, U.S.A., 2. St. Jude Children's Research Hospital, Memphis, U.S.A.)
[1S13a-05]Reciprocal crosstalk between tau pathology and inflammatory microglia: Imaging, mechanisms, and therapeutic targeting
*Makoto Higuchi1,2 (1. National Institutes for Quantum Science and Technology, 2. Osaka Metropolitan University Graduate School of Medicine)
[1S13a-06]Research on Drug Discovery Using iPS Cell Models for Tauopathy
*Keiko Imamura1 (1. Center for iPS Cell Research and Application, Kyoto university)